Lymphatic permeation and vascular invasion should not be integrated as lymphovascular invasion in lung adenocarcinoma
Volume: 69, Issue: 7, Pages: 1070 - 1078
Published: Jan 5, 2021
Abstract
Lymphatic permeation (LY) and vascular invasion (VI) are well-known as postoperative prognostic factors in non-small cell lung cancer (NSCLC). Some reports use the term “lymphovascular invasion (LVI)” in reference to the integration of LY and VI. The purpose in this study is to elucidate whether NSCLC with LY or VI can be labeled as LVI-positive NSCLC or it should be treated as an LY- or VI-positive tumor, respectively.
We reviewed 601...
Paper Details
Title
Lymphatic permeation and vascular invasion should not be integrated as lymphovascular invasion in lung adenocarcinoma
DOI
Published Date
Jan 5, 2021
Journal
Volume
69
Issue
7
Pages
1070 - 1078
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History